Aaron R Folsom1, Weihong Tang2, Kristen M George2, Susan R Heckbert3, Richard F MacLehose2, Mary Cushman4, James S Pankow2. 1. Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, United States. Electronic address: folso001@umn.edu. 2. Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, United States. 3. Department of Epidemiology, University of Washington, Seattle, WA 98101, United States. 4. Department of Medicine, University of Vermont, Burlington, VT 55446, United States; Department of Pathology, University of Vermont, Burlington, VT 05446, United States.
Abstract
INTRODUCTION: Epidemiological studies generally have not found plasma total fibrinogen to be a risk factor for venous thromboembolism (VTE), but several have reported associations between variants in the fibrinogen gamma gene (FGG) and VTE. A case-control study in whites suggested plasma γ' fibrinogen concentration may be associated inversely with VTE, but this was not replicated in African Americans. OBJECTIVE: To examine the prospective association between γ' fibrinogen concentrations and occurrence of VTE. METHODS: We used the Longitudinal Investigation of Thromboembolism Etiology (LITE), involving two pooled population-based cohorts in the United States including 16,234 participants. The cohorts comprised white and African American men and women, aged 50years and older at study onset in the early 1990s. We identified VTEs during follow-up and documented they met standardized diagnostic criteria. RESULTS: During two decades of follow-up, neither γ' fibrinogen nor total fibrinogen nor their ratio was associated with VTE overall (n=521 VTEs), in subgroups defined by race, or in other subgroups. In both race groups, the minor allele of FGG rs2066865 was associated with lower γ' fibrinogen concentrations, but this allele was not associated with VTE. CONCLUSIONS: A lower plasma concentration of γ' fibrinogen in healthy adults does not appear to increase VTE risk.
INTRODUCTION: Epidemiological studies generally have not found plasma total fibrinogen to be a risk factor for venous thromboembolism (VTE), but several have reported associations between variants in the fibrinogen gamma gene (FGG) and VTE. A case-control study in whites suggested plasma γ' fibrinogen concentration may be associated inversely with VTE, but this was not replicated in African Americans. OBJECTIVE: To examine the prospective association between γ' fibrinogen concentrations and occurrence of VTE. METHODS: We used the Longitudinal Investigation of Thromboembolism Etiology (LITE), involving two pooled population-based cohorts in the United States including 16,234 participants. The cohorts comprised white and African American men and women, aged 50years and older at study onset in the early 1990s. We identified VTEs during follow-up and documented they met standardized diagnostic criteria. RESULTS: During two decades of follow-up, neither γ' fibrinogen nor total fibrinogen nor their ratio was associated with VTE overall (n=521 VTEs), in subgroups defined by race, or in other subgroups. In both race groups, the minor allele of FGGrs2066865 was associated with lower γ' fibrinogen concentrations, but this allele was not associated with VTE. CONCLUSIONS: A lower plasma concentration of γ' fibrinogen in healthy adults does not appear to increase VTE risk.
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Shirley Uitte de Willige; Marieke C H de Visser; Jeanine J Houwing-Duistermaat; Frits R Rosendaal; Hans L Vos; Rogier M Bertina Journal: Blood Date: 2005-09-06 Impact factor: 22.113
Authors: George Davey Smith; Roger Harbord; Julie Milton; Shah Ebrahim; Jonathan A C Sterne Journal: Arterioscler Thromb Vasc Biol Date: 2005-08-25 Impact factor: 8.311
Authors: Marine Germain; Daniel I Chasman; Hugoline de Haan; Weihong Tang; Sara Lindström; Lu-Chen Weng; Mariza de Andrade; Marieke C H de Visser; Kerri L Wiggins; Pierre Suchon; Noémie Saut; David M Smadja; Grégoire Le Gal; Astrid van Hylckama Vlieg; Antonio Di Narzo; Ke Hao; Christopher P Nelson; Ares Rocanin-Arjo; Lasse Folkersen; Ramin Monajemi; Lynda M Rose; Jennifer A Brody; Eline Slagboom; Dylan Aïssi; France Gagnon; Jean-Francois Deleuze; Panos Deloukas; Christophe Tzourio; Jean-Francois Dartigues; Claudine Berr; Kent D Taylor; Mete Civelek; Per Eriksson; Bruce M Psaty; Jeanine Houwing-Duitermaat; Alison H Goodall; François Cambien; Peter Kraft; Philippe Amouyel; Nilesh J Samani; Saonli Basu; Paul M Ridker; Frits R Rosendaal; Christopher Kabrhel; Aaron R Folsom; John Heit; Pieter H Reitsma; David-Alexandre Trégouët; Nicholas L Smith; Pierre-Emmanuel Morange Journal: Am J Hum Genet Date: 2015-03-12 Impact factor: 11.025
Authors: Mary Cushman; Albert W Tsai; Richard H White; Susan R Heckbert; Wayne D Rosamond; Paul Enright; Aaron R Folsom Journal: Am J Med Date: 2004-07-01 Impact factor: 4.965
Authors: David H Farrell; Elizabeth A Rick; Elizabeth N Dewey; Martin A Schreiber; Susan E Rowell Journal: Am J Surg Date: 2019-12-28 Impact factor: 2.565
Authors: Christina R Cahill; Justin M Leach; Leslie A McClure; Marguerite Ryan Irvin; Neil A Zakai; Rakhi Naik; Frederick Unverzagt; Virginia G Wadley; Hyacinth I Hyacinth; Jennifer Manly; Suzanne E Judd; Cheryl Winkler; Mary Cushman Journal: EClinicalMedicine Date: 2019-05-24
Authors: Jillian Maners; Dipender Gill; Nathan Pankratz; Michael A Laffan; Alisa S Wolberg; Moniek P M de Maat; Symen Ligthart; Weihong Tang; Cavin K Ward-Caviness; Myriam Fornage; Stephanie Debette; Martin Dichgans; Barbara McKnight; Eric Boerwinkle; Nicholas L Smith; Alanna C Morrison; Abbas Dehghan; Paul S de Vries Journal: Blood Date: 2020-12-24 Impact factor: 22.113
Authors: Benedikte Paulsen; Hanne Skille; Erin N Smith; Kristian Hveem; Maiken E Gabrielsen; Sigrid K Brækkan; Frits R Rosendaal; Kelly A Frazer; Olga V Gran; John-Bjarne Hansen Journal: Haematologica Date: 2019-10-03 Impact factor: 9.941